$AXON

Bagley Brittany sold $2.9M of AXON

Bagley Brittany (COO & CFO) sold 5,969 shares of AXON ENTERPRISE, INC. (AXON) at $485.00 ($2.89M total) on 2026-06-02.

Original reporting
SEC EDGAR · Bagley Brittany
Published Jun 3, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 9:26 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AXON
Neutral
medium confidence
Mentioned
$AXON
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AXONNeutralLow
01

Why it matters

The disclosure updates the record of insider selling by a top executive but does not include any new company performance, guidance, or regulatory/legal developments.

02

Market read

Traders may briefly reassess sentiment around insider behavior, but there is no fundamental catalyst in the filing.

03

What to watch

The filing does not state a 10b5-1 plan, but insider sales can still be pre-planned or driven by personal needs; without additional context, signal quality is low.

Relevance 6/10Novelty 3/10Timing: filed 2026-06-03, transaction dated 2026-06-02

Background

The article is an SEC Form 4 insider transaction disclosure for Axon Enterprise, Inc.

Company-level read

Ticker impact

$AXONNeutralMedium confidence
Context

Axon Enterprise COO and CFO Bagley Brittany sold 5,969 shares at $485 on 2026-06-02, totaling about $2.89M, per Form 4.

Expected impact

Likely limited near-term impact; traders may view it as routine unless paired with other negative disclosures.

Evidence & confidence

Form 4 insider sales are common and this filing provides no new operational or financial guidance, but the officer role and absence of a stated 10b5-1 plan can attract short-term attention.

Market effects

No direct sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

The sale could be unrelated to fundamentals (taxes, diversification, planned liquidity), so it may not signal bearish expectations.

Key entities

  • AXON

    Axon Enterprise, Inc., the company whose insider transaction was filed.

  • Bagley Brittany

    COO and CFO who sold shares via an open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AXONMedAI 8/10

Axon’s AI Era Revenue Jumped Nearly 700%. Here’s What’s Behind It

Axon Enterprise (AXON) reported 35% revenue growth to $904M, beating estimates. AI Era revenue surged nearly 700% YoY. Management raised full-year guidance to 32-34% growth. Gross margin slipped 40 basis points to 62.9%. Analysts estimate a target price of $714, implying 13.7% upside over 2.4 years. The stock trades at 70x forward earnings, with growth driven by software and AI products.

$BABAHighAI 8/10

Breakfast News: Alibaba's AI Push Comes at a Cost

Alibaba's Q1 revenue rose 9% to $39.6B, but operating income fell 57% due to tech investments. BILL Holdings reported 14% revenue growth and 80% operating income increase. U.S. debt surpassed $40T, with Treasury buybacks easing yield pressure. Apple plans 2027 launch for camera AirPods. Axon Enterprise passes competitive position tests, with a 69% potential upside to $1,088.08.

$AXONMed

Axon Stock Rebounds As Its Margin Squeeze Looks Like The Price Of Growth

Axon Enterprise (AXON) shares rose 9.3% on Friday after a 14.3% drop the prior session following its Q2 2026 results. The quarter showed revenue of $904 million, up 35% year over year, and a raised full-year outlook. The market disagreed over margin compression tied to higher memory costs and counter-drone hardware mix, with Axon expecting Q3 adjusted EBITDA margin to hold and rebuild in Q4.

$AXONMed

Raise. So Why Is the Stock Down?

Axon Enterprise (NASDAQ: AXON) reported Q2 revenue of $904M, up 35% year over year, beating estimates of $876.5M. Adjusted EBITDA rose 40% to $242M, and adjusted EPS was $1.88 vs $1.84 expected. Axon raised full-year revenue guidance to 32%-34% growth but reduced software and services gross margin and withdrew operating cash flow and free cash flow guidance.